Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform
NCT ID: NCT06573476
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
180 participants
INTERVENTIONAL
2025-06-25
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
NCT06569667
Overdose Prevention Centers and Behavioral Health
NCT06236087
Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder
NCT04797962
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
NCT06806163
Mobile Peer Support for OUD Recovery
NCT05405712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Arm-1: PRC supported text+ AI driven CSDH-enhanced text
Individuals randomized to Arm-1 will receive PRC-supported text check-ins and AI-driven CSDH-enhanced text messaging.
PRC supported text + AI driven CSDH-enhanced text
In interventional Arm-1, PRC-supported text check-ins to participants (3x/week) will be provided by PRC study staff in addition to automated AI-driven texts. The PRC will personalize text "check-ins" to participants based on: (a) baseline CSDH needs (e.g., food insecurity, legal aid); (b) initial intake visit in primary care or challenges with service entry; and (c) content outlined in the CSH training addressing emerging participant challenges.
Intervention Arm-2: AI driven CSDH-enhanced text only
Individuals randomized to Arm-2 will receive the AI-driven CSDH-enhanced text messaging only
AI driven CSDH-enhanced text only
In interventional Arm-2, participants will receive the AI-driven CSDH-enhanced text messaging only. Participants in this arm will not receive text support from the PRC.
Control Arm 3- Treatment as Usual
Individuals randomized to the control arm will receive treatment as usual.
Treatment as Usual (TAU)
In Arm-3, the control group, individuals randomized to the control arm will receive treatment as usual (i.e., verbal instructions and NYC Dept of Health pamphlets detailing access to OUD and social services). No services will be provided except for social/clinical service referrals given at the end of each REDCap visit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRC supported text + AI driven CSDH-enhanced text
In interventional Arm-1, PRC-supported text check-ins to participants (3x/week) will be provided by PRC study staff in addition to automated AI-driven texts. The PRC will personalize text "check-ins" to participants based on: (a) baseline CSDH needs (e.g., food insecurity, legal aid); (b) initial intake visit in primary care or challenges with service entry; and (c) content outlined in the CSH training addressing emerging participant challenges.
AI driven CSDH-enhanced text only
In interventional Arm-2, participants will receive the AI-driven CSDH-enhanced text messaging only. Participants in this arm will not receive text support from the PRC.
Treatment as Usual (TAU)
In Arm-3, the control group, individuals randomized to the control arm will receive treatment as usual (i.e., verbal instructions and NYC Dept of Health pamphlets detailing access to OUD and social services). No services will be provided except for social/clinical service referrals given at the end of each REDCap visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fluent in English
* self-reported non-prescription opioid use \<30 days prior to consent
* provision of informed consent
* planned stay in NYC ≥3 months
* Black and/or Latinx race/ethnicity
* positive urine toxicology for opioids per EMR records or study staff administered random saliva drug testing
* diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
* self-reported interest in initiating buprenorphine in primary care, or elsewhere.
Exclusion Criteria
* physical or visual disability preventing mobile phone use
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nathan Kline Institute for Psychiatric Research
OTHER
NYU Langone Health
OTHER
Friends Research Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Ventuneac
Role: STUDY_DIRECTOR
START Treatment and Recovery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
START Treatment and Recovery
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.